Roswell Park Cancer Institute Corporation
Director- Utilities
David Klemenz in 2022 was employed at Roswell Park Cancer Institute Corporation and had an annual salary of $166,190 according to public records. This salary was 102 percent higher than the average and 191 percent higher than the median salary in Roswell Park Cancer Institute Corporation. David Klemenz reported rate of pay was $166,346 according to public records.
Roswell Park Cancer Institute Corporation records show David Klemenz held five jobs from 2010 to 2022. From 2021 to 2022 David Klemenz held job of Utilities Director.
In year 2022 David Klemenz's salary was 6 percent lower than average Director- Utilities salary in the state of New York.
Year | 2022 |
Full Name | David Klemenz |
Job Title | Director- Utilities |
Get Director- Utilities Salary Statistics | |
State | New York |
Employer | Roswell Park Cancer Institute Corporation |
Annual Wage | $166,190 |
Rate Of Pay | $166,346 |
Pay Basis | Annual |
Pay Plan |
*Information may include where available: salary, bonuses, benefits, retirement contributions, pensions, and other financial data.
Employer Name | Roswell Park Cancer Institute Corporation |
Year | 2022 |
Number of Employees | 4,109 |
Average Annual Wage | $82,308 |
Median Annual Wage | $57,017 |
David Klemenz (2022)Utilities Director | View Person Details |
David Klemenz (2021)Utilities Director | View Person Details |
David Klemenz (2019)Director Engineering And Maintenance [Rpci] | View Person Details |
David Klemenz (2014)Director Engineering & Maintenance | View Person Details |
David Klemenz (2013)Director Engineering & Maintenance | View Person Details |
David Klemenz (2012)Director Engineering & Maintenance | View Person Details |
David Klemenz (2011)Dir Capital Proj | View Person Details |
David Klemenz (2010)Dir Capital Proj [R] | View Person Details |
Kevin Eng Phd (2022)Associate Member at Roswell Park Cancer Institute Corporation | View Person Details |
Girma Agonafer (2022)Clinical Pharmacist - General at Roswell Park Cancer Institute Corporation | View Person Details |
Michael Spino (2022)Clinical Pharmacist - Investigational Drug Service at Roswell Park Cancer Institute Corporation | View Person Details |
Rodney Phd Haring (2022)Associate Member at Roswell Park Cancer Institute Corporation | View Person Details |
Marissa Walsh Pharmd (2022)Clinical Pharmacist - Specialist at Roswell Park Cancer Institute Corporation | View Person Details |
Linda Wickes (2022)Clinical Pharmacist - Investigational Drug Service at Roswell Park Cancer Institute Corporation | View Person Details |
Matthew Phd Buas (2022)Assistant Member at Roswell Park Cancer Institute Corporation | View Person Details |
Christopher Pharmd Sherrow (2022)Clinical Pharmacist - Specialist at Roswell Park Cancer Institute Corporation | View Person Details |
Michael Pharmd Faltas (2022)Executive Director at Roswell Park Cancer Institute Corporation | View Person Details |
Patricia Doucette (2022)Nurse Practitioner at Roswell Park Cancer Institute Corporation | View Person Details |